Herantis Pharma
1.99 EUR
-1.97 %
4,557 following
Corporate customer
HRTIS
First North Finland
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Investor consensus
Valuation
Income statement
Quarterly estimates
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Herantis Pharma
| Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26e | Q2/26e | Q3/26e | Q4/26e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
| EBITDA | -3.0 | -3.4 | -6.4 | -1.9 | -2.5 | ||||
| EBIT (adj.) | -3.0 | -3.4 | -6.4 | -1.9 | -2.5 | ||||
| EBIT | -3.0 | -3.4 | -6.4 | -1.9 | -2.5 | ||||
| EBIT-% (adj.) | -59,100.0 % | -68,880.0 % | -63,990.0 % | -37,087.2 % | -49,912.4 % | ||||
| EBIT-% | -59,100.0 % | -68,880.0 % | -63,990.0 % | -37,087.2 % | -49,912.4 % | ||||
| Profit before taxes | -0.1 | -3.1 | -0.1 | -3.3 | -6.6 | -2.1 | -2.5 | ||
| Net income | -0.1 | -3.1 | -0.1 | -3.3 | -6.6 | -2.1 | -2.5 |